|
Product Name：Weishike® Vitamin E Nicotinas Capsules |
| 【Major Indications】 |
HLP and atherosclerosis. |
【Amount of Usage】 |
Orally, recommended dose is 1-2 capsules each time, and 3 times daily. |
| 【Specifications】 |
0.1g×36 capsules； 0.1g×48 capsules per package. |
| |
|
|
Product Name：Benyue® Nicotinic Acid Sustained Release Tablets |
| 【Major Indications】 |
Cardiovascular disease in high risk caused by hypercholesterolemia. |
【Amount of Usage】 |
1-4 weeks: 1 tablet each time, once daily. |
| 【Specifications】 |
0.5g×10 tablets；0.5g×14 tablets；0.5g×20 tablets per package. |
| |
|
|
Product Name：Suiyue® Valsartan Capsules |
| 【Major Indications】 |
Mild and moderate essential hypertension. |
【Amount of Usage】 |
Orally, recommended dose is one capsule (80mg) each time, once daily. |
| 【Specifications】 |
80mg×12 capsules per package. |
| |
|
|
Product Name：Aisimo® Isosorbide Mononitrate Capsules（S R） |
| 【Major Indications】 |
Long term therapy for coronary heart disease; prevention for angina. |
【Amount of Usage】 |
Dose is various among individuals, please follow doctor prescription. For adult, recommended dose is one capsule for each time, once or twice daily. |
| 【Specifications】 |
40mg×12 capsules per package. |
| |
|
|
Product Name：Kabo® Finasteride Tablets |
| 【Major Indications】 |
Benign prostatic hyperplasia BPH. |
【Amount of Usage】 |
Orally, recommended dose is one tablet (5mg) each time, once daily. |
| 【Specifications】 |
5mg×10 tablets per package. |
| |
|
|
Product Name：Mashani® Terazosin Hydrochloride Tablets |
| 【Major Indications】 |
Hypertension and benign prostatic hyperplasia BPH. |
【Amount of Usage】 |
Orally, recommended dose is one tablet daily. Take before sleep. |
| 【Specifications】 |
2mg×14 tablets；2mg×20 tablets；2mg×28 tablets per package. |
| |
|
|
Product Name：Yashida® Amiodipine Besylate Tablets |
| 【Major Indications】 |
Hypertension and angina pectoris. |
【Amount of Usage】 |
Orally, recommended initial dose is one tablet (5mg) each time, and once daily. |
| 【Specifications】 |
5mg×7 tablets；5mg×14 tablets；5mg×20 tablets per package. |
| |
|
| |
